SPOTLIGHT -
Dea Belazi is President and CEO of AscellaHealth.
SPBMs: Impact on Accessibility & Affordability of Gene Therapies for Rare and Orphan Diseases
The introduction of alternative payment models and specialty pharmacy benefit management (SPBM) is poised to usher in a new era of affordability for expensive gene therapies.